Use of serum and urine metabolome analysis for the detection of metabolic changes in patients with stage 1-2 chronic kidney disease

Kaori Hayashi, Hiroyuki Sasamura, Takako Hishiki, Makoto Suematsu, Satsuki Ikeda, Tomoyoshi Soga, Hiroshi Itoh

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Chronic kidney disease (CKD) is a major health problem throughout the world, and understanding the pathological condition of CKD has become increasingly important. The recent development of advanced metabolomic assay techniques now allows the human metabolic condition to be evaluated sensitively and comprehensively. Objectives: The aim of this study was to use metabolomic analysis to perform a preliminary survey of metabolic changes occurring in patients with stage 1-2 CKD. Patients and Methods: Serum and urine metabolomic profiles of 15 patients with stage 1-2 CKD were analyzed using our previously reported capillary electrophoresis time-offlight mass spectrometry (CE-TOFMS) systems, and compared to 7 healthy volunteers. Results: The CE-TOFMS systems in three different modes for cation, anion, and nucleotide analyses detected multiple metabolites in serum and urine samples. In cation analysis mode, several increases in nonessential amino acids were identified in patients with stage 1-2 CKD, similar to those reported for end-stage renal disease (ESRD). Free-radical scavengers carnosine and hypotaurine were decreased in the urine, whereas serum hypotaurine and taurine were increased, consistent with changes in renal and/or systemic oxidative stress. Moreover, the cardiotoxin hypoxanthine was markedly increased in the serum, whereas serum and urine adenosine and urine guanine were decreased, suggesting changes in purine nucleotide metabolism which could affect cardiovascular prognosis. Changes in other unidentified metabolites were also detected. Conclusions: These results suggest that multiple changes in the metabolism are already detectable in stage 1-2 CKD using metabolome analysis. Further studies on these metabolic changes may result in new strategies to prevent cardiovascular events and progression to ESRD in patients with CKD.

Original languageEnglish
Pages (from-to)164-171
Number of pages8
JournalNephro-Urology Monthly
Volume3
Issue number3
Publication statusPublished - 2011

Fingerprint

Metabolome
Chronic Renal Insufficiency
Urine
Metabolomics
Serum
Capillary Electrophoresis
Chronic Kidney Failure
Cations
Mass Spectrometry
Cardiotoxins
Carnosine
Purine Nucleotides
Free Radical Scavengers
Hypoxanthine
Taurine
Guanine
Adenosine
Anions
Healthy Volunteers
Oxidative Stress

Keywords

  • Chronic kidney failure
  • Mass spectrometry
  • Metabolomics

ASJC Scopus subject areas

  • Urology

Cite this

Use of serum and urine metabolome analysis for the detection of metabolic changes in patients with stage 1-2 chronic kidney disease. / Hayashi, Kaori; Sasamura, Hiroyuki; Hishiki, Takako; Suematsu, Makoto; Ikeda, Satsuki; Soga, Tomoyoshi; Itoh, Hiroshi.

In: Nephro-Urology Monthly, Vol. 3, No. 3, 2011, p. 164-171.

Research output: Contribution to journalArticle

@article{bb1639e7fe1347acaf7b4caaea2ddb11,
title = "Use of serum and urine metabolome analysis for the detection of metabolic changes in patients with stage 1-2 chronic kidney disease",
abstract = "Background: Chronic kidney disease (CKD) is a major health problem throughout the world, and understanding the pathological condition of CKD has become increasingly important. The recent development of advanced metabolomic assay techniques now allows the human metabolic condition to be evaluated sensitively and comprehensively. Objectives: The aim of this study was to use metabolomic analysis to perform a preliminary survey of metabolic changes occurring in patients with stage 1-2 CKD. Patients and Methods: Serum and urine metabolomic profiles of 15 patients with stage 1-2 CKD were analyzed using our previously reported capillary electrophoresis time-offlight mass spectrometry (CE-TOFMS) systems, and compared to 7 healthy volunteers. Results: The CE-TOFMS systems in three different modes for cation, anion, and nucleotide analyses detected multiple metabolites in serum and urine samples. In cation analysis mode, several increases in nonessential amino acids were identified in patients with stage 1-2 CKD, similar to those reported for end-stage renal disease (ESRD). Free-radical scavengers carnosine and hypotaurine were decreased in the urine, whereas serum hypotaurine and taurine were increased, consistent with changes in renal and/or systemic oxidative stress. Moreover, the cardiotoxin hypoxanthine was markedly increased in the serum, whereas serum and urine adenosine and urine guanine were decreased, suggesting changes in purine nucleotide metabolism which could affect cardiovascular prognosis. Changes in other unidentified metabolites were also detected. Conclusions: These results suggest that multiple changes in the metabolism are already detectable in stage 1-2 CKD using metabolome analysis. Further studies on these metabolic changes may result in new strategies to prevent cardiovascular events and progression to ESRD in patients with CKD.",
keywords = "Chronic kidney failure, Mass spectrometry, Metabolomics",
author = "Kaori Hayashi and Hiroyuki Sasamura and Takako Hishiki and Makoto Suematsu and Satsuki Ikeda and Tomoyoshi Soga and Hiroshi Itoh",
year = "2011",
language = "English",
volume = "3",
pages = "164--171",
journal = "Nephro-Urology Monthly",
issn = "2251-7006",
publisher = "Kowsar Publishing Company",
number = "3",

}

TY - JOUR

T1 - Use of serum and urine metabolome analysis for the detection of metabolic changes in patients with stage 1-2 chronic kidney disease

AU - Hayashi, Kaori

AU - Sasamura, Hiroyuki

AU - Hishiki, Takako

AU - Suematsu, Makoto

AU - Ikeda, Satsuki

AU - Soga, Tomoyoshi

AU - Itoh, Hiroshi

PY - 2011

Y1 - 2011

N2 - Background: Chronic kidney disease (CKD) is a major health problem throughout the world, and understanding the pathological condition of CKD has become increasingly important. The recent development of advanced metabolomic assay techniques now allows the human metabolic condition to be evaluated sensitively and comprehensively. Objectives: The aim of this study was to use metabolomic analysis to perform a preliminary survey of metabolic changes occurring in patients with stage 1-2 CKD. Patients and Methods: Serum and urine metabolomic profiles of 15 patients with stage 1-2 CKD were analyzed using our previously reported capillary electrophoresis time-offlight mass spectrometry (CE-TOFMS) systems, and compared to 7 healthy volunteers. Results: The CE-TOFMS systems in three different modes for cation, anion, and nucleotide analyses detected multiple metabolites in serum and urine samples. In cation analysis mode, several increases in nonessential amino acids were identified in patients with stage 1-2 CKD, similar to those reported for end-stage renal disease (ESRD). Free-radical scavengers carnosine and hypotaurine were decreased in the urine, whereas serum hypotaurine and taurine were increased, consistent with changes in renal and/or systemic oxidative stress. Moreover, the cardiotoxin hypoxanthine was markedly increased in the serum, whereas serum and urine adenosine and urine guanine were decreased, suggesting changes in purine nucleotide metabolism which could affect cardiovascular prognosis. Changes in other unidentified metabolites were also detected. Conclusions: These results suggest that multiple changes in the metabolism are already detectable in stage 1-2 CKD using metabolome analysis. Further studies on these metabolic changes may result in new strategies to prevent cardiovascular events and progression to ESRD in patients with CKD.

AB - Background: Chronic kidney disease (CKD) is a major health problem throughout the world, and understanding the pathological condition of CKD has become increasingly important. The recent development of advanced metabolomic assay techniques now allows the human metabolic condition to be evaluated sensitively and comprehensively. Objectives: The aim of this study was to use metabolomic analysis to perform a preliminary survey of metabolic changes occurring in patients with stage 1-2 CKD. Patients and Methods: Serum and urine metabolomic profiles of 15 patients with stage 1-2 CKD were analyzed using our previously reported capillary electrophoresis time-offlight mass spectrometry (CE-TOFMS) systems, and compared to 7 healthy volunteers. Results: The CE-TOFMS systems in three different modes for cation, anion, and nucleotide analyses detected multiple metabolites in serum and urine samples. In cation analysis mode, several increases in nonessential amino acids were identified in patients with stage 1-2 CKD, similar to those reported for end-stage renal disease (ESRD). Free-radical scavengers carnosine and hypotaurine were decreased in the urine, whereas serum hypotaurine and taurine were increased, consistent with changes in renal and/or systemic oxidative stress. Moreover, the cardiotoxin hypoxanthine was markedly increased in the serum, whereas serum and urine adenosine and urine guanine were decreased, suggesting changes in purine nucleotide metabolism which could affect cardiovascular prognosis. Changes in other unidentified metabolites were also detected. Conclusions: These results suggest that multiple changes in the metabolism are already detectable in stage 1-2 CKD using metabolome analysis. Further studies on these metabolic changes may result in new strategies to prevent cardiovascular events and progression to ESRD in patients with CKD.

KW - Chronic kidney failure

KW - Mass spectrometry

KW - Metabolomics

UR - http://www.scopus.com/inward/record.url?scp=79959346092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959346092&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79959346092

VL - 3

SP - 164

EP - 171

JO - Nephro-Urology Monthly

JF - Nephro-Urology Monthly

SN - 2251-7006

IS - 3

ER -